NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.81
+0.87 (2.56%)
At close: Jan 22, 2026, 4:00 PM EST
34.81
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:00 PM EST
NAMS Market Cap
NAMS has a market cap or net worth of $3.95 billion as of January 22, 2026. Its market cap has increased by 42.10% in one year.
Market Cap
3.95B
Enterprise Value
3.19B
1-Year Change
42.10%
Ranking
Category
Stock Price
$34.81
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.95B, an increase of 2,454.88%. That is a compound annual growth rate of 92.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.85B | -3.25% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | 154.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 4.17B |
| Arcellx | 4.13B |
| Terns Pharmaceuticals | 4.05B |
| Ligand Pharmaceuticals | 3.87B |
| Corcept Therapeutics | 3.81B |
| Legend Biotech | 3.80B |
| Viking Therapeutics | 3.80B |
| Liquidia | 3.46B |